Annual revenue:
$2.36B+$468.20M(+24.81%)Summary
- As of today (April 14, 2025), NBIX annual revenue is $2.36 billion, with the most recent change of +$468.20 million (+24.81%) on December 1, 2024.
- During the last 3 years, NBIX annual revenue has risen by +$1.22 billion (+107.79%).
- NBIX annual revenue is now at all-time high.
Performance
NBIX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$627.70M+$5.60M(+0.90%)Summary
- As of today (April 14, 2025), NBIX quarterly revenue is $627.70 million, with the most recent change of +$5.60 million (+0.90%) on December 1, 2024.
- Over the past year, NBIX quarterly revenue has increased by +$112.40 million (+21.81%).
- NBIX quarterly revenue is now at all-time high.
Performance
NBIX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.36B+$112.50M(+5.02%)Summary
- As of today (April 14, 2025), NBIX TTM revenue is $2.36 billion, with the most recent change of +$112.50 million (+5.02%) on December 1, 2024.
- Over the past year, NBIX TTM revenue has increased by +$373.30 million (+18.83%).
- NBIX TTM revenue is now at all-time high.
Performance
NBIX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NBIX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.8% | +21.8% | +18.8% |
| 3 y3 years | +107.8% | +21.8% | +18.8% |
| 5 y5 years | +198.9% | +21.8% | +18.8% |
NBIX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.8% | at high | +102.1% | at high | +95.1% |
| 5 y | 5-year | at high | +198.9% | at high | +165.3% | at high | +165.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Neurocrine Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.36B(+24.8%) | $627.70M(+0.9%) | $2.36B(+5.0%) |
| Sep 2024 | - | $622.10M(+5.4%) | $2.24B(+5.8%) |
| Jun 2024 | - | $590.20M(+14.5%) | $2.12B(+6.9%) |
| Mar 2024 | - | $515.30M(+0.0%) | $1.98B(+5.0%) |
| Dec 2023 | $1.89B(+26.8%) | $515.20M(+3.3%) | $1.89B(+5.8%) |
| Sep 2023 | - | $498.80M(+10.2%) | $1.78B(+6.6%) |
| Jun 2023 | - | $452.70M(+7.7%) | $1.67B(+4.7%) |
| Mar 2023 | - | $420.40M(+2.0%) | $1.60B(+7.4%) |
| Dec 2022 | $1.49B(+31.3%) | $412.00M(+6.2%) | $1.49B(+7.2%) |
| Sep 2022 | - | $387.90M(+2.6%) | $1.39B(+7.1%) |
| Jun 2022 | - | $378.20M(+21.8%) | $1.30B(+7.4%) |
| Mar 2022 | - | $310.60M(-0.4%) | $1.21B(+6.5%) |
| Dec 2021 | $1.13B(+8.4%) | $312.00M(+5.4%) | $1.13B(+6.0%) |
| Sep 2021 | - | $296.00M(+2.5%) | $1.07B(+3.6%) |
| Jun 2021 | - | $288.90M(+22.1%) | $1.03B(-1.3%) |
| Mar 2021 | - | $236.60M(-4.6%) | $1.05B(-0.0%) |
| Dec 2020 | $1.05B(+32.7%) | $247.90M(-4.1%) | $1.05B(+0.4%) |
| Sep 2020 | - | $258.50M(-14.5%) | $1.04B(+3.6%) |
| Jun 2020 | - | $302.40M(+27.5%) | $1.01B(+13.4%) |
| Mar 2020 | - | $237.10M(-2.9%) | $886.80M(+12.5%) |
| Dec 2019 | $788.10M(+74.7%) | $244.10M(+9.9%) | $788.10M(+16.7%) |
| Sep 2019 | - | $222.10M(+21.0%) | $675.45M(+11.6%) |
| Jun 2019 | - | $183.50M(+32.6%) | $605.11M(+16.7%) |
| Mar 2019 | - | $138.40M(+5.3%) | $518.51M(+14.9%) |
| Dec 2018 | $451.20M(+179.2%) | $131.45M(-13.4%) | $451.20M(+8.9%) |
| Sep 2018 | - | $151.76M(+56.6%) | $414.26M(+28.1%) |
| Jun 2018 | - | $96.91M(+36.3%) | $323.28M(+38.9%) |
| Mar 2018 | - | $71.09M(-24.8%) | $232.71M(+44.0%) |
| Dec 2017 | $161.63M(+977.5%) | $94.52M(+55.5%) | $161.63M(+140.8%) |
| Sep 2017 | - | $60.77M(+859.3%) | $67.11M(+959.3%) |
| Jun 2017 | - | $6.33M(-57.8%) | $6.33M(-57.8%) |
| Dec 2016 | $15.00M(-24.1%) | - | - |
| Mar 2016 | - | $15.00M(-24.1%) | $15.00M(-24.1%) |
| Dec 2015 | $19.77M(+577.3%) | - | - |
| Mar 2015 | - | $19.77M(+2608.1%) | $19.77M(+577.3%) |
| Dec 2013 | $2.92M(-94.5%) | $730.00K(+0.1%) | $2.92M(-87.9%) |
| Sep 2013 | - | $729.00K(-0.1%) | $24.14M(-26.3%) |
| Jun 2013 | - | $730.00K(0.0%) | $32.76M(-23.1%) |
| Mar 2013 | - | $730.00K(-96.7%) | $42.60M(-19.8%) |
| Dec 2012 | $53.14M(-31.4%) | $21.95M(+134.6%) | $53.14M(+25.6%) |
| Sep 2012 | - | $9.36M(-11.5%) | $42.30M(-43.3%) |
| Jun 2012 | - | $10.57M(-6.2%) | $74.58M(-2.1%) |
| Mar 2012 | - | $11.27M(+1.4%) | $76.17M(-1.6%) |
| Dec 2011 | $77.41M(+131.1%) | $11.11M(-73.3%) | $77.41M(-3.2%) |
| Sep 2011 | - | $41.63M(+242.5%) | $79.96M(+51.5%) |
| Jun 2011 | - | $12.16M(-2.8%) | $52.77M(+16.6%) |
| Mar 2011 | - | $12.51M(-8.4%) | $45.26M(+35.1%) |
| Dec 2010 | $33.50M(+1034.5%) | $13.66M(-5.5%) | $33.50M(+62.8%) |
| Sep 2010 | - | $14.45M(+211.2%) | $20.58M(+199.7%) |
| Jun 2010 | - | $4.64M(+516.6%) | $6.87M(+132.1%) |
| Mar 2010 | - | $753.00K(+1.8%) | $2.96M(+0.2%) |
| Dec 2009 | $2.95M | $740.00K(+1.0%) | $2.95M(+0.4%) |
| Sep 2009 | - | $733.00K(0.0%) | $2.94M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $733.00K(-1.9%) | $2.97M(-0.0%) |
| Mar 2009 | - | $747.00K(+2.5%) | $2.97M(-25.3%) |
| Dec 2008 | $3.98M(+224.8%) | $729.00K(-4.2%) | $3.98M(+5.2%) |
| Sep 2008 | - | $761.00K(+3.7%) | $3.78M(+6.2%) |
| Jun 2008 | - | $734.00K(-58.1%) | $3.56M(+23.9%) |
| Mar 2008 | - | $1.75M(+229.1%) | $2.87M(+134.6%) |
| Dec 2007 | $1.22M(-96.9%) | $532.00K(-1.5%) | $1.22M(-87.9%) |
| Sep 2007 | - | $540.00K(+1025.0%) | $10.13M(-5.0%) |
| Jun 2007 | - | $48.00K(-53.8%) | $10.67M(-46.3%) |
| Mar 2007 | - | $104.00K(-98.9%) | $19.86M(-49.4%) |
| Dec 2006 | $39.23M(-68.3%) | $9.44M(+779.0%) | $39.23M(-10.6%) |
| Sep 2006 | - | $1.07M(-88.4%) | $43.91M(-59.2%) |
| Jun 2006 | - | $9.24M(-52.5%) | $107.58M(-18.2%) |
| Mar 2006 | - | $19.48M(+38.0%) | $131.50M(+6.1%) |
| Dec 2005 | $123.89M(+45.5%) | $14.11M(-78.2%) | $123.89M(-3.4%) |
| Sep 2005 | - | $64.75M(+95.2%) | $128.26M(+30.6%) |
| Jun 2005 | - | $33.17M(+179.6%) | $98.22M(+22.6%) |
| Mar 2005 | - | $11.86M(-35.8%) | $80.10M(-6.0%) |
| Dec 2004 | $85.18M(-38.8%) | $18.48M(-46.7%) | $85.18M(-9.2%) |
| Sep 2004 | - | $34.70M(+130.6%) | $93.83M(+6.2%) |
| Jun 2004 | - | $15.05M(-11.2%) | $88.38M(-25.3%) |
| Mar 2004 | - | $16.94M(-37.6%) | $118.30M(-14.9%) |
| Dec 2003 | $139.08M(+670.7%) | $27.14M(-7.3%) | $139.08M(+20.1%) |
| Sep 2003 | - | $29.26M(-34.9%) | $115.82M(+26.5%) |
| Jun 2003 | - | $44.97M(+19.2%) | $91.55M(+80.2%) |
| Mar 2003 | - | $37.72M(+872.6%) | $50.80M(+181.5%) |
| Dec 2002 | $18.05M(-56.2%) | $3.88M(-22.2%) | $18.05M(-33.2%) |
| Sep 2002 | - | $4.98M(+17.9%) | $27.00M(-38.1%) |
| Jun 2002 | - | $4.23M(-14.7%) | $43.61M(+2.1%) |
| Mar 2002 | - | $4.96M(-61.4%) | $42.71M(+3.6%) |
| Dec 2001 | $41.24M(+182.7%) | $12.83M(-40.6%) | $41.24M(+29.1%) |
| Sep 2001 | - | $21.59M(+548.8%) | $31.95M(+103.7%) |
| Jun 2001 | - | $3.33M(-4.6%) | $15.68M(+2.5%) |
| Mar 2001 | - | $3.49M(-1.6%) | $15.30M(+4.9%) |
| Dec 2000 | $14.59M(-13.2%) | $3.54M(-33.4%) | $14.59M(-4.3%) |
| Sep 2000 | - | $5.32M(+80.9%) | $15.24M(+0.8%) |
| Jun 2000 | - | $2.94M(+5.9%) | $15.12M(-5.4%) |
| Mar 2000 | - | $2.78M(-33.9%) | $15.99M(-4.9%) |
| Dec 1999 | $16.80M(+5.0%) | $4.20M(-19.2%) | $16.81M(-1.8%) |
| Sep 1999 | - | $5.20M(+36.5%) | $17.11M(+0.6%) |
| Jun 1999 | - | $3.81M(+5.8%) | $17.01M(+9.7%) |
| Mar 1999 | - | $3.60M(-20.0%) | $15.50M(-3.1%) |
| Dec 1998 | $16.00M(-38.7%) | $4.50M(-11.8%) | $16.00M(-9.6%) |
| Sep 1998 | - | $5.10M(+121.7%) | $17.70M(-5.9%) |
| Jun 1998 | - | $2.30M(-43.9%) | $18.80M(-11.7%) |
| Mar 1998 | - | $4.10M(-33.9%) | $21.30M(-18.4%) |
| Dec 1997 | $26.10M(+35.9%) | $6.20M(0.0%) | $26.10M(-10.6%) |
| Sep 1997 | - | $6.20M(+29.2%) | $29.20M(+15.9%) |
| Jun 1997 | - | $4.80M(-46.1%) | $25.20M(-2.7%) |
| Mar 1997 | - | $8.90M(-4.3%) | $25.90M(+34.9%) |
| Dec 1996 | $19.20M | $9.30M(+322.7%) | $19.20M(+93.9%) |
| Sep 1996 | - | $2.20M(-60.0%) | $9.90M(+28.6%) |
| Jun 1996 | - | $5.50M(+150.0%) | $7.70M(+250.0%) |
| Mar 1996 | - | $2.20M | $2.20M |
FAQ
- What is Neurocrine Biosciences annual revenue?
- What is the all time high annual revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual revenue year-on-year change?
- What is Neurocrine Biosciences quarterly revenue?
- What is the all time high quarterly revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly revenue year-on-year change?
- What is Neurocrine Biosciences TTM revenue?
- What is the all time high TTM revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM revenue year-on-year change?
What is Neurocrine Biosciences annual revenue?
The current annual revenue of NBIX is $2.36B
What is the all time high annual revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual revenue is $2.36B
What is Neurocrine Biosciences annual revenue year-on-year change?
Over the past year, NBIX annual revenue has changed by +$468.20M (+24.81%)
What is Neurocrine Biosciences quarterly revenue?
The current quarterly revenue of NBIX is $627.70M
What is the all time high quarterly revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly revenue is $627.70M
What is Neurocrine Biosciences quarterly revenue year-on-year change?
Over the past year, NBIX quarterly revenue has changed by +$112.40M (+21.81%)
What is Neurocrine Biosciences TTM revenue?
The current TTM revenue of NBIX is $2.36B
What is the all time high TTM revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM revenue is $2.36B
What is Neurocrine Biosciences TTM revenue year-on-year change?
Over the past year, NBIX TTM revenue has changed by +$373.30M (+18.83%)